Our vision

Every year, fewer than 10,000 patients worldwide receive radiotherapy with carbon ions, helium or other ions — a tiny proportion compared to the 20 million new cancer cases recorded each year globally¹ ².

Yet international analyses estimate that at least 5% of cancer patients could benefit from carbon ion radiotherapy if it were available on a large scale³ — that is nearly one million patients per year worldwide.

1 PTCOG – Particle Therapy Patient Statistics (2022–2023).
2 IARC – GLOBOCAN, global cancer incidence.
3 Malouff T.D. et al., Estimating the Number of Patients Eligible for Carbon Ion Radiotherapy, IJPT (2020).

Our mission

The primary mission of Normandy Hadrontherapy is the design, development, manufacturing, installation, industrialisation and subsequent commercialisation of a first hadrontherapy research and treatment system based on cyclotron technology. Hadrontherapy is a form of radiotherapy that uses beams of accelerated protons and ions to treat radio-resistant tumours: it represents a hope for more effective and less impactful treatment for patients suffering from resistant cancers. The technological solution proposed by NHa aims to make hadrontherapy (proton therapy and carbon ion beam treatment) accessible to clinical treatment centres.

Strategic board

Gérard MESTRALLET

FORMER CEO OF ENGIE AND SUEZ

Olivier LEGRAIN

CEO, IBA

Sophie GAUGAIN

GENERAL DIRECTOR, SAPHYN

Olivier NICOLLE

REGIONAL DIRECTOR, VINCI CONSTRUCTION

François FONTAINE

GENERAL ADVISOR, SFPI (BELGIAN SOVEREIGN WEALTH FUND)​

Gery LEFEVRE

INVESTMENT MANAGER, WALLONIE ENTREPRENDRE

Sebastien LONGELIN

CEO, SIGMAPHI

Our team

Christophe LE FOLL

Co-Chairman

Christophe is co-CEO of NHa.
He has committed to building a project that is both useful and sustainable. On a day-to-day basis, his mission is to give the teams the means to move forward with clarity and efficiency: structuring the organisation, supporting decision-making and ensuring that every decision translates into concrete actions.

Jefferson SORRIAUX

Co-Chairman

As co-CEO of NHa, Jefferson’s mission is to transform technological innovation into robust, differentiated and value-creating product solutions.
He oversees R&D and operations in order to manage and reduce technical and industrial risks, while defining a strategic trajectory that aligns innovation, competitiveness and sustainable growth.

Virgile LETELLIER

Medical Physicist

Virgile is an expert in the medicalisation of particle beams to reduce side effects in radiotherapy.
He designs and deploys cutting-edge technologies in treatment rooms. He analyses medical trends to propose innovative product solutions.
Virgile is the medical and scientific point of reference within the international oncology community.

Imane MASSELIS

Project Manager

Imane is a Project Manager.
She coordinates activities related to the C400 installation, ensuring that all defined project objectives are met.
Her main responsibilities include planning and coordination, risk management and problem solving, as well as project performance monitoring.

Marc DE LEENHEER

Chief Operating Officer

As Chief Operating Officer at NHa, Marc coordinates the installation, procurement, methods and industrialisation teams to ensure the quality, reliability and schedule control of a complex technology project, balancing technical performance, economic constraints and organisational agility.

Richard BORYS

Production and Installation

Richard manages production and installation activities and also leads the team.
His responsibilities include the organisation and coordination of internal, external and material resources for the development, manufacturing and installation of the equipment.

Maxime DUFOUR-TRIVINI

Supply Chain Manager

Head of Supply Chain, Maxime oversees all purchasing, logistics and supplier quality activities. His role is to secure the supply of critical components, optimise flows and ensure component compliance and supplier reliability. Working closely with internal teams, he contributes to the company’s overall performance.

Discover the rest of the team